Alvogen Group Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
2,800
- Latest Deal Type
-
Debt
- Financing Rounds
-
17
- Investments
-
17
Alvogen Group General Information
Description
Manufacturer of specialty pharmaceutical generic and branded products dedicated to helping people live long healthy and active lives. The company offers a broad range of leading molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology, ensuring affordable generic medications that help reduce healthcare costs around the world.
Contact Information
Website
www.alvogen.comCorporate Office
- 44 Whippany Road
- Suite 300
- Morristown, NJ 07960
- United States
Corporate Office
- 44 Whippany Road
- Suite 300
- Morristown, NJ 07960
- United States
Alvogen Group Timeline
Alvogen Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Alvogen Group Comparisons
Industry
Financing
Details
00000
000000
Alvogen Group Competitors (37)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Merck & Co. | Corporation | Rahway, NJ | 00000 | 0000 | 000000000 - | 0000 |
| Bluefish Pharmaceuticals | Private Equity-Backed | Stockholm, Sweden | 000 | 000.00 | 00000000000 | |
| Mankind Pharma | Formerly PE-Backed | New Delhi, India | 00000 | 00000 | 00000000 | 00000 |
| Rising Pharmaceuticals | Private Equity-Backed | East Brunswick, NJ | 000 | 00000000000 | ||
| Camber Pharmaceuticals | Corporation | Piscataway, NJ | 000 | 000000000 - |
Alvogen Group Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alvogen Group Patents
Alvogen Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3760190-B1 | Controlled-release tablets of pregabalin, method of making, and method of use thereof | Active | 03-Jul-2019 | 0000000000 | |
| EP-3760190-A1 | Controlled-release tablets of pregabalin, method of making, and method of use thereof | Active | 03-Jul-2019 | 0000000000 | 0 |
| US-20210000775-A1 | Controlled-release tablets, method of making, and method of use thereof | Active | 03-Jul-2019 | 0000000000 | 0 |
| ES-2953059-T3 | Pregabalin controlled release tablets, method of manufacture, and method of use thereof | Active | 03-Jul-2019 | 0000000000 | |
| US-11974974-B2 | Controlled-release tablets, method of making, and method of use thereof | Active | 03-Jul-2019 | A61K31/197 | 00 |
Alvogen Group Executive Team (23)
| Name | Title | Board Seat |
|---|---|---|
| Tunie Zaku | US Chief Financial Officer | |
| Arni Hardarson | Deputy to the CEO & Board Member | |
| Thuc Nguyen | Chief Representative | |
| Robert Wessman | Founder & Chairman | |
| Travis Roberts | Vice President of US Sales and Marketing Generics |
Alvogen Group Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 000000000 | Alvogen Group | Deputy to the CEO & Board Member | 000 0000 |
| 00000000000 00ø000 | CVC Capital Partners | Board Member | 000 0000 |
| 00000 0000 | Temasek Holdings | Board Member | 000 0000 |
| 000000 0000000 | Alvogen Group | Founder & Chairman | 000 0000 |
| 00000 00000 | CVC Capital Partners | Board Member | 000 0000 |
Alvogen Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Alvogen Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Alvogen Group Investments & Acquisitions (17)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Alvotech | 23-Oct-2020 | 00 0000000 | 00000 | Biotechnology | 000000 00 |
| Assertio Therapeutics (Gralise) | 13-Jan-2020 | 0000000000 | 0000 | Buildings and Property | |
| Bittner Pharma | 21-Jul-2017 | 0000000000 | Pharmaceuticals | 00000 000 | |
| County Line Pharmaceuticals | 13-Apr-2016 | 0000000000 | 00000 | Pharmaceuticals | 000000 00 |
| Bayer Pharma (five hormonal branded products) | 06-Oct-2015 | Buyout/LBO | Other Healthcare Services | 00000 000 |
Alvogen Group Subsidiaries (4)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Almatica Pharma | Pharmaceuticals | Morristown, NJ | 2007 |
| Lotus Pharmaceutical | Pharmaceuticals | Taipei City, Taiwan | 0000 |
| Alvogen Korea | Pharmaceuticals | Seoul, South Korea | 0000 |
| Almaject | Medical Supplies | Morristown, NJ |
Alvogen Group FAQs
-
When was Alvogen Group founded?
Alvogen Group was founded in 2007.
-
Who is the founder of Alvogen Group?
Robert Wessman is the founder of Alvogen Group.
-
Who is the CEO of Alvogen Group?
Lisa Graver JD is the CEO of Alvogen Group.
-
Where is Alvogen Group headquartered?
Alvogen Group is headquartered in Morristown, NJ.
-
What is the size of Alvogen Group?
Alvogen Group has 2,800 total employees.
-
What industry is Alvogen Group in?
Alvogen Group’s primary industry is Pharmaceuticals.
-
Is Alvogen Group a private or public company?
Alvogen Group is a Private company.
-
What is Alvogen Group’s current revenue?
The current revenue for Alvogen Group is 000000.
-
How much funding has Alvogen Group raised over time?
Alvogen Group has raised $434M.
-
Who are Alvogen Group’s investors?
Athyrium Capital Management, CVC Capital Partners, and Temasek Holdings have invested in Alvogen Group.
-
Who are Alvogen Group’s competitors?
Merck & Co., Bluefish Pharmaceuticals, Mankind Pharma, Rising Pharmaceuticals, and Camber Pharmaceuticals are some of the 37 competitors of Alvogen Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
